ShareThis Page

Oncologist shares expertise with biology class

| Sunday, March 17, 2013, 9:00 p.m.
Dr. David Friedland, an oncologist with UPMC Hillman Cancer Center, speaks to McKeesport Area High School students about cancer statistics and cellular processes.
Jennifer R. Vertullo | Daily News
Dr. David Friedland, an oncologist with UPMC Hillman Cancer Center, speaks to McKeesport Area High School students about cancer statistics and cellular processes.

Expanding on lessons in cell biology, McKeesport Area High School students learned about the impact of cancer and the scientific advances that are progressing in its treatment.

Dr. David Friedland, an oncologist with Hillman Cancer Center of UPMC's CancerCenter network, visited Marla Hayes' biology classes on Tuesday to talk about what causes cancer, how it impacts patients and their families and what today's scientists and doctors are doing to manage the broad scope of diseases characterized by unregulated cell growth.

The American Cancer Society describes cancer as a group of more than 100 diseases, caused by abnormal cells that grow out of control, that can cause serious illness and death.

With the body made up of trillions of living cells, cancer can initiate almost anywhere.

Normal cells grow, divide and die, Friedland explained. When an interruption in that process causes cells to divide improperly in mass quantities without ending their life cycle, cancer can result.

“Cancer, by contrast to normal tissue, is totally disorganized,” he said. “Cancer cells, almost by definition, are immortal. They don't die. They just keep dividing and dividing.”

In cancer treatment, the goal is to induce cell death.

Friedland discussed surgery, which removes an accessible mass; radiation, which uses high-energy waves to destroy cancer cells; chemotherapy, which attacks a wide range of cells with medicine; hormonal therapy, which suppresses natural hormones that trigger some cancers; immunotherapy, which utilizes the body's own immune system in cancer treatment; and targeted therapy, which is a newer medical treatment that attacks cancer cells while doing little damage to normal cells.

“That's really the new horizon in cancer treatment,” Friedland said. “And in the treatment of most cancers, chemotherapy will go away.”

Even with targeted treatments, there are a variety of drugs that initiate death in cancerous cells. Friedland likened the methods to different ways to stop a doorbell from ringing.

“You can put a board over the button so nobody can get to it. You can cut the wires to eliminate the connection. Or you could attack the guy who's trying to ring the bell,” he explained.

Some of the targeted therapy drugs attack abnormal proteins or enzymes that form inside cancer cells. Others block enzymes that promote cell growth, and therefore prevent cancer from spreading.

Friedland said scientists are learning new things about cancer biology on a daily basis. And while strides continue to be made, there is more to learn about the microscopic world.

“Hopefully, some of you here will become scientists and figure this stuff out,” he said.

Hayes confirmed that the biology field — not only in studying cancer cells — is changing rapidly with time.

“At one time, biology class was about dissecting animals,” Hayes recalled. “Now, it's about cells. We know so much more about biological processes.”

Indicating that she teaches through traditional textbooks and experiments, Hayes said she isn't an expert in real-life biological applications. She wanted students to hear from a true expert in the field of cancer diagnosis and treatment.

“Dr. Friedland is a genuine, normal guy with a lot of knowledge and experience,” she said, noting he has treated her husband Chris Hayes for several years since his cancer diagnosis at age 27. “Students get to see for themselves what it took for him to get there.”

Sophomore Amy Cicci said the presentation was interesting and informative.

“He was so detailed on the process,” she said. “I was intrigued by his explanation of how cancer progresses, especially knowing that we can delay and in some cases prevent it.”

Jennifer R. Vertullo is a staff writer for Trib Total Media. She can be reached at 412-664-9161, ext. 1956, or

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.